Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30229165 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL29385320 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL14403006 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL31695032 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL8472884 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL24508220 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL19249321 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL15343919 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL14410347 | 1.00 | NANP (0.33) | NANPTDP1 | |
| SCHEMBL28686289 | 1.00 | NANP (0.33) | NANPTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12038447-B2 | Lipid bilayer membrane mimic | Sellergren, Börje (SE) | 2024-07-16 | — | — | US | disclosed |
| EP-3706802-B1 | LIPID BILAYER MEMBRANE MIMIC | SELLERGREN BOERJE (SE) | 2024-06-05 | — | — | EP | disclosed |
| US-20200355707-A1 | LIPID BILAYER MEMBRANE MIMIC | SELLERGREN, BORJE (SE) | 2020-11-12 | — | — | US | disclosed |
| EP-3706802-A1 | LIPID BILAYER MEMBRANE MIMIC | Sellergren, Börje (SE) | 2020-09-16 | — | — | EP | disclosed |
| US-20190209710-A1 | DIAGNOSTIC SENSOR AND CHEWING GUM COMPRISING SUCH A DIAGNOSTIC SENSOR FOR THE TASTE-BASED DETECTION OF VIRUSES | JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (DE) | 2019-07-11 | — | — | US | disclosed |
| US-20080113924-A1 | Neuramindase Inhibitor | NATIONAL INSTITUE OF ADVANCE INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190209710-A1 | DIAGNOSTIC SENSOR AND CHEWING GUM COMPRISING SUCH A DIAGNOSTIC SENSOR FOR THE TASTE-BASED DETECTION OF VIRUSES | TAS2R10, TAS2R16, TAS2R5 | NANP 184/4885TDP1 2453/4885 |
| US-20080113924-A1 | Neuramindase Inhibitor | NMBR, NEU1, NMUR1 | NANP 183/4885TDP1 3832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.